Page 4 - Junction Pharmacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Updated Jan 28, 2021 | 18:17 IST Even marginal changes in the rate of transmissibility can have outsize impacts concerning the total number of cases and casualties. A pharmacist administers a dose of the Oxford/AstraZeneca vaccine to an individual at a coronavirus vaccination clinic held at Junction Pharmacy in Brixton, London, Thursday, Jan. 28, 2021.   |  Photo Credit: AP Key Highlights For the most part, subtle changes in a virus' genetic code are unimportant and harmless but as these mutations accumulate, the probability of a virus becoming more transmis...

US biotech firm Novavax announced its vaccine had successfully completed Phase Three clinical trials in UK Under a deal with the UK government, 60million doses of the vaccine will be produced on Teesside for UK use The vaccine still requires final approval from the UK's Medicines and Healthcare products Regulatory Agency The firm Novavax last night said that the trials had shown its coronavirus vaccine was 89.3 per cent effective This trial is the first to be completed since the emergence of the new variant of the Covid-19 disease in Kent